| Literature DB >> 15380265 |
Vivian Tullio1, Annamaria Cuffini, Narcisa Mandras, Janira Roana, Giuliana Banche, Domenico Ungheri, Nicola Carlone.
Abstract
Current antibiotic therapy encourages the use of antibiotics that may potentiate the host's immune defences. We therefore investigated the effect of thiamphenicol (TAP), the active principle of thiamphenicol glycinate acetylcysteinate (TGA), on human granulocyte functions, mainly phagocytosis and intracellular killing of Streptococcus pyogenes. Our findings support the use of thiamphenicol in the treatment of respiratory tract infections caused by S. pyogenes as it acts directly against the pathogen as well as in cooperation with PMNs by eliciting their intracellular killing.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15380265 DOI: 10.1016/j.ijantimicag.2004.03.027
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN: 0924-8579 Impact factor: 5.283